Dersalazine

Drug Profile

Dersalazine

Alternative Names: UR-12746

Latest Information Update: 03 Aug 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Uriach
  • Class Anti-inflammatories; Benzoic acids; Small molecules
  • Mechanism of Action Platelet activating factor inhibitors; Tumour necrosis factor alpha inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Ulcerative colitis

Highest Development Phases

  • Discontinued Ulcerative colitis

Most Recent Events

  • 25 Nov 2009 No development reported - Phase-I for Crohn's disease in Spain (PO)
  • 22 Oct 2008 Pharmacodynamics data from a preclinical trial presented at the 16th United European Gastroenterology Week (UEGW-2008)
  • 25 Jul 2007 Phase I development is ongoing
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top